299 related articles for article (PubMed ID: 23545497)
1. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.
Wang P; Yang L; Cheng G; Yang G; Xu Z; You F; Sun Q; Lin R; Fikrig E; Sutton RE
Cell Rep; 2013 Apr; 3(4):1057-70. PubMed ID: 23545497
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
3. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome.
Zhang L; Liu J; Qian L; Feng Q; Wang X; Yuan Y; Zuo Y; Cheng Q; Miao Y; Guo T; Zheng X; Zheng H
PLoS Pathog; 2018 May; 14(5):e1007067. PubMed ID: 29734366
[TBL] [Abstract][Full Text] [Related]
4. MAVS self-association mediates antiviral innate immune signaling.
Tang ED; Wang CY
J Virol; 2009 Apr; 83(8):3420-8. PubMed ID: 19193783
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
[TBL] [Abstract][Full Text] [Related]
7. Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.
Cao Z; Xia Z; Zhou Y; Yang X; Hao H; Peng N; Liu S; Zhu Y
Sci Rep; 2016 Sep; 6():33557. PubMed ID: 27629939
[TBL] [Abstract][Full Text] [Related]
8. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
[TBL] [Abstract][Full Text] [Related]
9. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter.
Belgnaoui SM; Paz S; Hiscott J
Curr Opin Immunol; 2011 Oct; 23(5):564-72. PubMed ID: 21865020
[TBL] [Abstract][Full Text] [Related]
10. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of RIG-I-mediated antiviral signaling by TRK-fused gene (TFG) protein.
Lee NR; Shin HB; Kim HI; Choi MS; Inn KS
Biochem Biophys Res Commun; 2013 Jul; 437(1):168-72. PubMed ID: 23810392
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
13. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
14. NOD1 Promotes Antiviral Signaling by Binding Viral RNA and Regulating the Interaction of MDA5 and MAVS.
Wu XM; Zhang J; Li PW; Hu YW; Cao L; Ouyang S; Bi YH; Nie P; Chang MX
J Immunol; 2020 Apr; 204(8):2216-2231. PubMed ID: 32169843
[TBL] [Abstract][Full Text] [Related]
15. NLRP11 disrupts MAVS signalosome to inhibit type I interferon signaling and virus-induced apoptosis.
Qin Y; Su Z; Wu Y; Wu C; Jin S; Xie W; Jiang W; Zhou R; Cui J
EMBO Rep; 2017 Dec; 18(12):2160-2171. PubMed ID: 29097393
[TBL] [Abstract][Full Text] [Related]
16. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
[TBL] [Abstract][Full Text] [Related]
19. Both STING and MAVS fish orthologs contribute to the induction of interferon mediated by RIG-I.
Biacchesi S; Mérour E; Lamoureux A; Bernard J; Brémont M
PLoS One; 2012; 7(10):e47737. PubMed ID: 23091644
[TBL] [Abstract][Full Text] [Related]
20. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
